Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. Allweiss L, Volmari A, Suri V, Wallin JJ, et al. J Hepatol 2024 Feb 8:S0168-8278(24)00114-4. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Allweiss L, Volmari A, Suri V, Wallin JJ, et al. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. J Hepatol 2024 Feb 8:S0168-8278(24)00114-4. doi: 10.1016/j.jhep.2024.
PMID: 38340811